Ongentys Capsule
Product Images NDC 64896-402

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ongentys (NDC 64896-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ongentys Contains Opicapone, A Peripheral, Selective And Reversible Catechol-o-methyltransferase (comt) Inhibitor. The Chemical Name Of Opicapone Is 2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide With The Following Structure: (Ongentys Opicapone Capsules 1)

FDA Label Image

25 mg 30 Ct Label (Ongentys Opicapone Capsules 2)

FDA Label Image

50 mg 30 Ct Label (Ongentys Opicapone Capsules 3)